According to the announcement of Baolingbao Biology, it is estimated that the net income attributable to the shareholders of the listed company from January 1st, 2024 to June 30th, 2024 will be between 58 million yuan and 75 million yuan, a year-on-year increase of 77.05% to 128.94%; after deducting non-recurring gains and losses, the net income will be between 57 million yuan and 70 million yuan, a year-on-year increase of 212.55% to 283.83%. The growth in performance is mainly due to the company's optimization of production processes for probiotics, dietary fiber, and sweetener products, resulting in lower production costs, as well as lower prices for key raw materials and energy purchases. In addition, the company has adjusted its marketing strategy and optimized its product structure, which has significantly improved the gross margin.
保龄宝：上半年净利润预增77.05%-128.94%
Baolingbao Biology: Net income for the first half of the year is expected to increase by 77.05%-128.94%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.